| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.6 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |